Instrumentos de recolección de información

Attal M, Huguet F, Schlaifer D (1992). Intensive combined therapy for previously untreated aggressive myeloma. Blood, 79: 1130-1136.

Attal M, Harrousseau J-L, Stoppa A-M et al. (1996). A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med, 335: 91-97.

Alcorn MJ, Farrell E, Barr J et.al. (2000). The number of CD34+ cells mobilized into the peripheral blood can predict the quality of subsequent collections. J Hematother Stem Cell Res., 9: 89-93.

Barlogie B, Jagannath S, Vesole DH et al. (1997). Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood, 89: 789-793.

Barlogie B. et al. (1999). Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood, 93: 55-65.

Bastion et al. (1995). Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86: 3257-3262.

Bensinger WI, Longin K, Appelbaum F et al. (1994). Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG- CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol. 87: 825-831.

Bensinger WI, Appelbaum F, Rowly S et al. (1995). Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol, 13: 2547- 2555.

Beyer J, Schwella N, Zingsem J et al. (1995). Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol; 13: 1328-35.

Brice P, Marolleau JP, Pautier P et al. (1996). Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: Comparison of bone marrow and peripheral blood progenitor cells. Leukemia and Lymphoma, 22; 449- 456.

Brunvand MW, Bensinger WI, Soll E et al. (1996). High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. Bone Marrow Transplantation, 18: 131-141.

Cavin JA, Scheer SC, Thomas ED et al. (1964).The recovery of lethally irradiated dogs given infusions of autologous leukocytes preserved at -80 C. Blood, 23: 38-43.

Corso A, Caberlon S, Pagnucco G et. al. (2000). Blood stem cell collections in multiple myeloma: definition of a scoring system. Bone marrow transplant. 26, 283- 286.

Craig et al. (1993). Peripheral blood stem cell mobilization using high-dose cyclophosphamide and G-CSF in pretreated patients with lymphoma. Br J Haematol, 85: 210-212.

Cunningham D, Paz-Arez L, Milan S et al. (1994). High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol, 12: 759-763.

Demirer T, Buckner CD, Gooley T et al. (1996). Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplantation, 17: 937-941.

Demirer T, Buckner CD, Storer B et al. (1997). Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte-stimulating factor. J Clin Oncol, 15: 684-690.

Dreger P, Klöss M, Petersen B et al. (1995). Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood, 86: 3970-3978.

Elliott et al. (1996). When to harvest peripheral-blood-stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol, 14 (3): 970-973.

Engelhardt et al. (1997). Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin´s lymphoma patients after combination chemotherapy and G-CSF. Bone Marrow Transplantation, 19: 529-537.

Freedman et al. (1996). High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88: 2780-2786.

Gianni AM, Siena S, Bregni M et al. (1989). Granulocyte-macrophage colony- stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet, 8663: 580-585.

Gianni AM (1994). Where do we stand with respect to the use of peripheral blood progenitor cells? Annals of Oncology, 5: 781-784.

Goodman JW, Hodgson GS (1962). Evidence for stem cells in the peripheral blood of mice. Blood, 19: 702-14.

Gordon MY, Clarke D, Atkinson J et al. (1990). Hemopoietic progenitor cell binding to the stromal microenvironment in vitro. Experimental Hematology, 18: 837-842.

Haas R, Hohaus S, Egerer G (1992). Recombinant human granulocyt-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplantation, 9: 459-65.

Haas R, Möhle R, Fruehauf S et. al. (1994). Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83: 3787-3794.

Hansson M, Svensson A, Engervall P et al. (1995). Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration. Eur J Haematol, 54: 321-328.

Hartmann O, Gaelle Le Corroller A, Blaise D et al. (1997). Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: Hematologic recovery and costs. Ann Intern Med, 126: 600-607.

Henon Ph R, Liang H, Beck-Wirth G et al. (1992). Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplantation; 9: 285-91.

Jones HM, Jones SA, Watts MJ (1994). Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol, 12: 1693-1702.

Juttner CA, To LB, Haylock DN (1985). Circulating stem cells collected in very early remission from acute non-lymphoblastic leukemia produce prompt but incomplete hematopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol, 61: 739-45.

Kessinger A, Armitage JO, Landmark JD et al. (1986). Reconstitution of human hematopoietic function with autologous cryopresserved circulating stem cells. Exp. Hematology, 14: 192-96.

Knudsen LM, Gaarsdal E, Jensen L et al. (1998). Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis. J Hematother, 7: 45-52.

Körbling M, Fliedner TM, Pflieger H (1980). Collection of large quantities of granulocyte/macrophage progenitor cells (CFUc) in man by means of Continuous- Flow Apheresis. Scand J Haematol, 24: 22-28.

Körbling M, Dörken B, Ho AD et al. (1986). Autologous transplantation of blood- derived hemopoietic stem cells after myeloablative therapy in a patient with burkitt`s lymphoma. Blood, 67: 529-32.

Krieger MS, Schiller G, Berenson JR et.al. (1999). Collection of peripheral blood progenitor cells (PBPC) based on rising WBC and platelet count significantly increases the number of CD34-cells. Bone Marrow Transplant., 24: 25-28.

Liberti G, Pearce R, Taghipour G et al. (1994). Comparison of peripheral blood stem- cell and autologous bone marrow transplantation for lymphoma patients: A case- controlled analysis of the EBMT Registry data. Annals of Oncology, 5 (Suppl 2): 151- 153.

Lie et al. (1996). Progenitor cell yield in sequential blood stem cell mobilization in the same patients: Insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy. Br J Haematol, 95: 39-44.

Majolino I, Pearce R, Taghipour G et al. (1995). PBSCT vs. ABMT in Hodgkin`s and non-Hodgkin`s lymphomas: A new matched-pair analysis of the EBMT registry data. Bone Marrow Transplant, 15: 162.

McCredie KB, Hersh EM, Freireich EJ (1971). Cells capable of colony formation in the peripheral blood of man. Science, 171: 293-4.

McElwain TJ, Powles RL (1983). High-dose intravenous melphalan for plasma-cell leukemia and myeloma. Lancet, 8354: 822-824.

McQuaker IG, Haynes AP, Stainer C et al.,(1997). Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamid, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol, 98: 228-233.

Moskowitz et al. (1999). Ifosfamide, carboplatin and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin‘s lymphoma. J Clin Oncol, 17 (12): 3776-3785.

Negrin RS, Claus R et al. (1995). Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin´s lymphoma. Blood, 85: 3334-41.

Palumbo et al. (1999). Dose-intensive Melphalan with stem cell support (Mel100) is superior to standard treatment in elderly myeloma patients. Blood, 94: 1248-1253.

Perez-Simon JA, Caballero MD, Corral M et al. (1998). Minimal number of circulating CD-34+cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion, 38: 385-390.

Pettengell R, Testa NG, Swindell R et al (1993). Transplantation Potential of hematopoietic cells released into the circulation during routine chemotherapy for non- Hodgkin´s lymphoma. Blood, 82: 2239-48.

Pettengell R (1995). Expanding the role of blood progenitor cells. Annals of Oncology, 6: 759-767.

Philip T, Guglielmi C, Hagenbeek A et al. (1995). Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin`s lymphoma. New England Journal of Medicine, 333: 1540-1545.

Reiffers J, Bernard P, David B et al. (1986). Successful autologous transplantation with peripheral blood hemopoietic cells in a patient acute leukemia. Exp. Hematology, 14: 312-15.

Remes K, Matinlauri I, Grenman S et al. (1997). Daily measurements of blood CD-34 cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. J. Hematother, 6: 13-19.

Richman CM, Weiner RS, Yankee RA (1976). Increase in circulating stem cells following chemotherapy in man. Blood, 47: 1031-9.

Rosenfeld CS, Gremba C, Shadduck RK et al. (1994). Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Exp Hematology; 22: 290-294.

Russell NH, Pacey S (1992). Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet, 340: 1290.

Schmitz N, Linch DC, Dreger P et al. (1996). Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma. Lancet, 347: 353-357.

Schwella et al. (1996). Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol, 14 (4): 1114-1121.

Sheridan WP, Begley CG, Juttner CA et al. (1992). Effect of peripheral-blood progenitor cells mobilized by filgrastim ( G-CSF ) on platelet recovery after high-dose chemotherapy. Lancet; 339: 640-4.

Siena S, Bregni M, Brando B et al. (1991). Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77: 400-409.

Simmons PJ, Masinovsky B, Longenecker BM (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80: 388-395.

Smith TJ, Hillner BE, Schmitz N et al. (1997). Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin`s and non-Hodgkin`s lymphoma. J Clin Oncol, 15: 5-10.

Socinski MA, Elias A, Schnipper L et al (1988). Granulocyte- macrophage colony stimulating factor expands the circulating hematopoietic progenitor cell compartment in man. Lancet, 8596: 1194.

To LB, Roberts MM, Haylock DN et al (1992). Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogenic bone marrow transplants. Bone Marrow Transplantation, 9: 277-84.

Tricot G, Jagannath S, Vesole D (1995). Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood, 85: 588-596.

Udomsakdi C, Lansdorp PM, Hogge DE et al (1992). Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood, 80: 2513-2521.

Watts MJ, Sullivan AM, Jamieson E et al (1997). Progenitor cell mobilization after low-dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor: An Analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol, 15: 535-546.

Weaver CH, Hazelton B, Birch R (1995). An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood, 86: 3961- 3969.

Weaver et al. (2000). Randomized trial of filgrastim, Sargramostim or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells. J Clin Oncol, 18 (1): 43-53.

Williams O, Demirer T, Lilleby K et al. (1998). Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization. J Clin Apheresis, 13: 1-6.

LEBENSLAUF

Angaben zur Person

Name: Christine Herzog, geb. von Osten Geburtsort: Ludwigshafen/Rhein

Geburtsdatum: 30. 01. 1971

Familienstand: verheiratet mit Dr. med. Christopher Herzog 2 Kinder: Charlotte (3J.) & Maximilian (1J.) Staatsangehörigkeit: deutsch

Schulbildung

1977 - 1981 Grundschule an der Waldlehne / Essen 1981 - 1990 Grashof - Gymnasium / Essen

1990 Abitur

Ausbildung

1990 – 1992 Staatliche Ausbildung für technische Assistenten in der

Medizin (Labor) Medizinstudium 1993 -1995 Albert-Ludwigs-Universität, Freiburg 03/1995 Ärztliche Vorprüfung 1995/1999 Ludwig-Maximilians-Universität, München 03/1996 1. Staatsexamen 03/1998 2. Staatsexamen

1998 - 1999 Praktisches Jahr (Klinikum Großhadern, LMU München / Broussais-Hôtel Dieu, Université de Paris)

11/1999 3. Staatsexamen

6.1.1.1 Berufliche Tätigkeit

seit 05/2000 AIP in Pneumologie/Allergologie, 2. Klinik für Innere Medizin der Johann Goethe Universität Frankfurt (Dir.: Prof. Dr. T. O. F. Wagner)

Meine Danksagung gilt vor allem Herrn PD Dr. Christian Straka, Oberarzt der……, der mich mit außerordentlichem Bemühen und persönlichem Einsatz durch die Jahre der Arbeit begleitete. Er führte mich in das wissenschaftliche Arbeiten ein und war mir stets durch sein offenes Ohr für Sachfragen jeglicher Art ein vorbildhafter Mentor. Ich danke ihm für die Bereicherung, die mein Studium hierdurch erfuhr.

Danken möchte ich auch Herrn Prof. Dr. B. Emmerich, Leiter der Hämato-Onkologie der Medizinischen Klinik Innenstadt, der mir die Möglichkeit gab, bei Ihm zu promovieren.

Großer Dank gilt auch Frau Brigitte Schnabel, die mir zu jeder Zeit hilfreich zur Seite stand und vor allem nach meinem Umzug nach Frankfurt mit großem Einsatz half, die Arbeit trotz der räumlichen Distanz zu Ende stellen zu können.